Literature DB >> 12147641

Mental health promotion and illness prevention in Western Australia: a study of service capacity.

Sue Robinson1, Duane Pennebaker.   

Abstract

While considerable evidence exists regarding the effectiveness of specific kinds of interventions for mental illness prevention and to a lesser extent mental health promotion, mental health promotion and illness prevention (MHPIP) remain underdeveloped in Western Australia. The aim of this study was to explore the current state of MHPIP in Western Australia and to highlight some of the structural and systemic issues that need to be addressed if MHPIP services are to be progressed further in this state. For this purpose, the study examined the capacity for delivery of MHPIP services. Opportunities and barriers to the further development of MHPIP were also identified. Thirty-four key stakeholders representing a cross-section of local services, central government agencies and universities were interviewed using a semi-structured interview schedule. The interviews were conducted over a 6-week period. The interview schedule included questions on the workforce, agency liaison and project implementation, and priority areas and issues with respect to research and policy setting in MHPIP. In developing the focus of MHPIP services, critical factors that constitute capacity building were identified. These included readiness to participate in MHPIP, service infrastructure development, workforce development, resource allocation, networks and evaluation of programmes.

Entities:  

Mesh:

Year:  2002        PMID: 12147641     DOI: 10.1093/heapro/17.3.263

Source DB:  PubMed          Journal:  Health Promot Int        ISSN: 0957-4824            Impact factor:   2.483


  1 in total

1.  Education in mental health promotion and its impact on the participants' attitudes and perceived mental health.

Authors:  Vlassis D Tomaras; Maria Ginieri-Coccossis; Maria Vassiliadou; Melpomeni Malliori; Spyros Ferentinos; Constantin R Soldatos; Andre Tylee
Journal:  Ann Gen Psychiatry       Date:  2011-12-23       Impact factor: 3.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.